ATNM 净利润历史(2016–2025)
Actinium Pharmaceuticals, Inc. (ATNM) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
-$33.9MFY2025 · FY2016 以来:-$24.3M → -$33.9M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$33.9M | +11.4% |
| FY2024 | -$38.2M | +21.7% |
| FY2023 | -$48.8M | -47.9% |
| FY2022 | -$33.0M | -33.3% |
| FY2021 | -$24.8M | -11.5% |
| FY2020 | -$22.2M | -1.4% |
| FY2019 | -$21.9M | +7.4% |
| FY2018 | -$23.7M | +11.1% |
| FY2017 | -$26.6M | -9.4% |
| FY2016 | -$24.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议